XML 38 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
2024 Preferred Stock ATM Program
Preferred Stock
Common Stock
2024 ATM Program
Common Stock
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
2024 ATM Program
Additional Paid-In Capital
2024 Preferred Stock ATM Program
Additional Paid-In Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
2024 ATM Program
2024 Preferred Stock ATM Program
Total
Balance at Dec. 31, 2021   $ 30   $ 60       $ 85,414   $ 343,459 $ 1,517       $ 430,480
Increase (decrease) in shareholders' equity                              
Net Income (Loss) Attributable to the Company                   3,158         3,158
Three-for-One Stock Split       122       (122)              
Stock Repurchase       (1)       (2,791)             (2,792)
Vested Restricted Stock and Performance Shares               (845)             (845)
Exercise of Stock Options and Common Stock Issuance               315             315
Stock Issuance, Net of Costs and Expenses       48       94,803             94,851
Stock-Based Compensation Expense               2,731             2,731
Preferred Stock Dividends Declared for the Period                   (4,781)         (4,781)
Common Stock Dividends Declared for the Period                   (29,579)         (29,579)
Other Comprehensive Income (Loss)                     14,244       14,244
Balance at Dec. 31, 2022   30   229 $ (7,034)     172,471 $ 4,022 316,279 15,761 $ (3,012)     504,770
Increase (decrease) in shareholders' equity                              
Net Income (Loss) Attributable to the Company                   5,530         5,530
Stock Repurchase       (4)       (6,435)             (6,439)
Vested Restricted Stock and Performance Shares       1       (1,029)             (1,028)
Stock Issuance to Directors               375             375
Common Stock Equity Issuance Costs               (175)             (175)
Stock-Based Compensation Expense               3,228             3,228
Preferred Stock Dividends Declared for the Period                   (4,772)         (4,772)
Common Stock Dividends Declared for the Period                   (35,093)         (35,093)
Other Comprehensive Income (Loss)                     (8,870)       (8,870)
Balance at Dec. 31, 2023   30   226       168,435   281,944 6,891       457,526
Increase (decrease) in shareholders' equity                              
Net Income (Loss) Attributable to the Company                   (1,965)         (1,965)
Stock Repurchase               (664)             (664)
Vested Restricted Stock and Performance Shares       1       (1,275)             (1,274)
Stock Issuance to Directors               647             647
Stock Issuance, Net of Costs and Expenses $ 17   $ 90     $ 164,738 $ 32,979           $ 164,828 $ 32,996  
Stock-Based Compensation Expense               2,968             2,968
Preferred Stock Dividends Declared for the Period                   (6,814)         (6,814)
Common Stock Dividends Declared for the Period                   (41,076)         (41,076)
Other Comprehensive Income (Loss)                     5,626       5,626
Balance at Dec. 31, 2024   $ 47   $ 317       $ 367,828   $ 232,089 $ 12,517       $ 612,798